Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Roche Sells Drugs of Abuse Testing Business to Varian

By HospiMedica staff writers
Posted on 12 Feb 2003
In a move to divest a business whose market is not important to the company's current strategy, Roche Diagnostics (Basel, Switzerland) has sold its worldwide nonclinical drugs of abuse testing (DAT) business to Varian, Inc. More...
(Palo Alto, CA) for an undisclosed amount.

Included in the sale were Roche's OnTrak TesTcup, OnTrak TesTstik, OnSite alcohol and Intect line of testing devices, all commonly used for illicit drug screening in the workplace and in the criminal justice system. The sale does not include Roche's drugs of abuse testing products used by clinical and hospital laboratory customers. Roche will continue to sell and support the OnTrak TesTcard 9 drugs of abuse testing product and all Abuscreen Online assays for drug abuse.

"When reviewing other companies who were interested in purchasing this business, we sought buyers who were closely aligned with the marketplace to continue growing this business,” said Martin Madaus, president and CEO of Roche Diagnostics, North America.





Related Links:
Roche Diagnostics
Varian

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Urine Analyzer
respons® UDS100
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.